Catalyst
Slingshot members are tracking this event:
Phase 3 Studies of Inclisiran for Hypercholesterolemia Expected to Start in the First Half of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ALNY |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 26, 2017
Occurred Source:
http://investors.alnylam.com/releasedetail.cfm?ReleaseID=1022930
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Hypercholesterolemia, Inclisiran, Phase 3
